Improved prediction and characterization of anticancer activities of peptides using a novel flexible scoring card method

Abstract As anticancer peptides (ACPs) have attracted great interest for cancer treatment, several approaches based on machine learning have been proposed for ACP identification. Although existing methods have afforded high prediction accuracies, however such models are using a large number of descr...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Phasit Charoenkwan, Wararat Chiangjong, Vannajan Sanghiran Lee, Chanin Nantasenamat, Md. Mehedi Hasan, Watshara Shoombuatong
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/4da6028b3ec44c70afc3d6b6a8e19110
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:4da6028b3ec44c70afc3d6b6a8e19110
record_format dspace
spelling oai:doaj.org-article:4da6028b3ec44c70afc3d6b6a8e191102021-12-02T10:44:21ZImproved prediction and characterization of anticancer activities of peptides using a novel flexible scoring card method10.1038/s41598-021-82513-92045-2322https://doaj.org/article/4da6028b3ec44c70afc3d6b6a8e191102021-02-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-82513-9https://doaj.org/toc/2045-2322Abstract As anticancer peptides (ACPs) have attracted great interest for cancer treatment, several approaches based on machine learning have been proposed for ACP identification. Although existing methods have afforded high prediction accuracies, however such models are using a large number of descriptors together with complex ensemble approaches that consequently leads to low interpretability and thus poses a challenge for biologists and biochemists. Therefore, it is desirable to develop a simple, interpretable and efficient predictor for accurate ACP identification as well as providing the means for the rational design of new anticancer peptides with promising potential for clinical application. Herein, we propose a novel flexible scoring card method (FSCM) making use of propensity scores of local and global sequential information for the development of a sequence-based ACP predictor (named iACP-FSCM) for improving the prediction accuracy and model interpretability. To the best of our knowledge, iACP-FSCM represents the first sequence-based ACP predictor for rationalizing an in-depth understanding into the molecular basis for the enhancement of anticancer activities of peptides via the use of FSCM-derived propensity scores. The independent testing results showed that the iACP-FSCM provided accuracies of 0.825 and 0.910 as evaluated on the main and alternative datasets, respectively. Results from comparative benchmarking demonstrated that iACP-FSCM could outperform seven other existing ACP predictors with marked improvements of 7% and 17% for accuracy and MCC, respectively, on the main dataset. Furthermore, the iACP-FSCM (0.910) achieved very comparable results to that of the state-of-the-art ensemble model AntiCP2.0 (0.920) as evaluated on the alternative dataset. Comparative results demonstrated that iACP-FSCM was the most suitable choice for ACP identification and characterization considering its simplicity, interpretability and generalizability. It is highly anticipated that the iACP-FSCM may be a robust tool for the rapid screening and identification of promising ACPs for clinical use.Phasit CharoenkwanWararat ChiangjongVannajan Sanghiran LeeChanin NantasenamatMd. Mehedi HasanWatshara ShoombuatongNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-13 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Phasit Charoenkwan
Wararat Chiangjong
Vannajan Sanghiran Lee
Chanin Nantasenamat
Md. Mehedi Hasan
Watshara Shoombuatong
Improved prediction and characterization of anticancer activities of peptides using a novel flexible scoring card method
description Abstract As anticancer peptides (ACPs) have attracted great interest for cancer treatment, several approaches based on machine learning have been proposed for ACP identification. Although existing methods have afforded high prediction accuracies, however such models are using a large number of descriptors together with complex ensemble approaches that consequently leads to low interpretability and thus poses a challenge for biologists and biochemists. Therefore, it is desirable to develop a simple, interpretable and efficient predictor for accurate ACP identification as well as providing the means for the rational design of new anticancer peptides with promising potential for clinical application. Herein, we propose a novel flexible scoring card method (FSCM) making use of propensity scores of local and global sequential information for the development of a sequence-based ACP predictor (named iACP-FSCM) for improving the prediction accuracy and model interpretability. To the best of our knowledge, iACP-FSCM represents the first sequence-based ACP predictor for rationalizing an in-depth understanding into the molecular basis for the enhancement of anticancer activities of peptides via the use of FSCM-derived propensity scores. The independent testing results showed that the iACP-FSCM provided accuracies of 0.825 and 0.910 as evaluated on the main and alternative datasets, respectively. Results from comparative benchmarking demonstrated that iACP-FSCM could outperform seven other existing ACP predictors with marked improvements of 7% and 17% for accuracy and MCC, respectively, on the main dataset. Furthermore, the iACP-FSCM (0.910) achieved very comparable results to that of the state-of-the-art ensemble model AntiCP2.0 (0.920) as evaluated on the alternative dataset. Comparative results demonstrated that iACP-FSCM was the most suitable choice for ACP identification and characterization considering its simplicity, interpretability and generalizability. It is highly anticipated that the iACP-FSCM may be a robust tool for the rapid screening and identification of promising ACPs for clinical use.
format article
author Phasit Charoenkwan
Wararat Chiangjong
Vannajan Sanghiran Lee
Chanin Nantasenamat
Md. Mehedi Hasan
Watshara Shoombuatong
author_facet Phasit Charoenkwan
Wararat Chiangjong
Vannajan Sanghiran Lee
Chanin Nantasenamat
Md. Mehedi Hasan
Watshara Shoombuatong
author_sort Phasit Charoenkwan
title Improved prediction and characterization of anticancer activities of peptides using a novel flexible scoring card method
title_short Improved prediction and characterization of anticancer activities of peptides using a novel flexible scoring card method
title_full Improved prediction and characterization of anticancer activities of peptides using a novel flexible scoring card method
title_fullStr Improved prediction and characterization of anticancer activities of peptides using a novel flexible scoring card method
title_full_unstemmed Improved prediction and characterization of anticancer activities of peptides using a novel flexible scoring card method
title_sort improved prediction and characterization of anticancer activities of peptides using a novel flexible scoring card method
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/4da6028b3ec44c70afc3d6b6a8e19110
work_keys_str_mv AT phasitcharoenkwan improvedpredictionandcharacterizationofanticanceractivitiesofpeptidesusinganovelflexiblescoringcardmethod
AT wararatchiangjong improvedpredictionandcharacterizationofanticanceractivitiesofpeptidesusinganovelflexiblescoringcardmethod
AT vannajansanghiranlee improvedpredictionandcharacterizationofanticanceractivitiesofpeptidesusinganovelflexiblescoringcardmethod
AT chaninnantasenamat improvedpredictionandcharacterizationofanticanceractivitiesofpeptidesusinganovelflexiblescoringcardmethod
AT mdmehedihasan improvedpredictionandcharacterizationofanticanceractivitiesofpeptidesusinganovelflexiblescoringcardmethod
AT watsharashoombuatong improvedpredictionandcharacterizationofanticanceractivitiesofpeptidesusinganovelflexiblescoringcardmethod
_version_ 1718396760894734336